Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment.
作者信息
Edahiro Ryuya, Shiroyama Takayuki, Hijiki Sachiko, Nojima Satoshi, Shirai Yuya, Koyama Shohei, Kumanogoh Atsushi
机构信息
Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
出版信息
Lung Cancer. 2020 Feb;140:116-117. doi: 10.1016/j.lungcan.2019.12.004. Epub 2019 Dec 9.
Abstract
摘要
相似文献
1
Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment.
Lung Cancer. 2020 Feb;140:116-117. doi: 10.1016/j.lungcan.2019.12.004. Epub 2019 Dec 9.
2
Combined checkpoint inhibitor-associated myocarditis and pulmonary vasculitis mimicking acute pulmonary embolism.
Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):243. doi: 10.1093/ehjci/jey191.
3
[Fulminant myocarditis caused by nivolumab treatment for non-small cell lung cancer (NSCLC): a case report].
Zhonghua Zhong Liu Za Zhi. 2020 Dec 23;42(12):1047-1048. doi: 10.3760/cma.j.cn112152-20200116-00042.
4
Immunotherapy- A double Edged Sword; A case of Fatal Myocarditis and Complete Response.
Ir Med J. 2019 May 9;112(5):937.
5
Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade.
Eur J Cancer. 2020 Jun;132:224-227. doi: 10.1016/j.ejca.2020.03.003. Epub 2020 Apr 24.
6
Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.
Eur J Cancer. 2019 Jan;107:93-96. doi: 10.1016/j.ejca.2018.11.021. Epub 2018 Dec 13.
7
Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.
J Thorac Oncol. 2019 Feb;14(2):e36-e38. doi: 10.1016/j.jtho.2018.10.156. Epub 2018 Nov 1.
8
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding.
J Thorac Oncol. 2018 Dec;13(12):e247-e248. doi: 10.1016/j.jtho.2018.07.013.
9
Nivolumab-induced Pancreatitis: An Immune-related Adverse Event.
Radiology. 2019 Dec;293(3):521. doi: 10.1148/radiol.2019191603. Epub 2019 Oct 15.
10
Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.
N Engl J Med. 2019 Jun 13;380(24):2377-2379. doi: 10.1056/NEJMc1901677.
引用本文的文献
1
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review.
Cardiovasc Toxicol. 2024 Nov;24(11):1174-1191. doi: 10.1007/s12012-024-09918-6. Epub 2024 Sep 10.
2
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response.
Clin Pharmacol. 2022 Aug 10;14:69-90. doi: 10.2147/CPAA.S369008. eCollection 2022.
3
Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis.
Cardiol Res. 2021 Oct;12(5):270-278. doi: 10.14740/cr1319. Epub 2021 Sep 29.
Zotero 插件